The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

A team of scientists have developed a simple method for automated manufacturing of lung organoids which could revolutionize ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

The research highlights the role of immune checkpoint inhibitors, drugs that enhance the body's ability to fight tumors.

The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...

WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...